Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
Titel:
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
Auteur:
Malorni, L. Curigliano, G. Minisini, A.M. Cinieri, S. Tondini, C.A. D’Hollander, K. Arpino, G. Bernardo, A. Martignetti, A. Criscitiello, C. Puglisi, F. Pestrin, M. Sanna, G. Moretti, E. Risi, E. Biagioni, C. McCartney, A. Boni, L. Buyse, M. Migliaccio, I. Biganzoli, L. Di Leo, A.